LITTLE KNOWN FACTS ABOUT MBL77.

Not all patients with CLL require therapy. Inspite of all the latest advancements, the iwCLL nevertheless endorses watchful observation for patients with asymptomatic condition.86 This suggestion relies on not less than two randomized trials evaluating observation to possibly chlorambucil monotherapy or fludarabine, cyclophosphamide and rituximab (